A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.

Published in: Fertil Steril.
By: Chu M, Cosper P, Nakhuda GS, Lobo RA.

Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.

Published in: Obstet Gynecol
By: Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, Vittinghoff E, Grady D

Menopausal hormone therapy for vasomotor symptoms: Balancing the risks and benefits with ultra-low doses of estrogen.

Published in: Expert Opin Investig Drugs.
By: Simon JA, Snabes MC.

Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.

Published in: Menopause
By: Hemelaar M, Kenemans P, Hack CE, Klipping C, and van der Mooren MJ.

Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.

Published in: Am J Obstet Gynecol.
By: Chu MC, Cushman M, Solomon R, Lobo RA.

Effects of the route of estrogen administration on insulin like growth factor-1, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.

Published in: Menopause.
By: Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.

Androgen therapy in women.

Published in: Eur J Endocrinol.
By: Arlt W.

Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone binding globulin, estradiol, and estrone levels.

Published in: Menopause.
By: Nachtigall LE, Raju U, Banerjee S, Wan L, Levitz M.

Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.

Published in: Circulation
By: Vehkavaara S, Hakala-Ala-Pietila T, Virkamaki A, Bergholm R, Ehnholm C, Hovatta O, et al.

The use of estrogen therapy in women’s sexual functioning.

Published in: J Sex Med.
By: Nappi RE, Polatti F.

Pages